Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. - Wikidata - awgldk - TriplyDB

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

http://www.wikidata.org/entity/Q35209239

about

Anti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overview Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities Mitochondrial Molecular Pathophysiology of Nonalcoholic Fatty Liver Disease: A Proteomics Approach Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine Bone marrow derived stem cells for the treatment of end-stage liver disease Hydrogen Sulfide as a Potential Therapeutic Target in Fibrosis Oxidative Stress and Liver Cancer: Etiology and Therapeutic Targets PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer Pyrroloquinoline-quinone suppresses liver fibrogenesis in mice Liver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cells Liver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.Liver Shear-Wave Velocity and Serum Fibrosis Markers to Diagnose Hepatic Fibrosis in Patients with Chronic Viral Hepatitis B Recent advances in molecular magnetic resonance imaging of liver fibrosis Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids miR-106b-25/miR-17-92 clusters: polycistrons with oncogenic roles in hepatocellular carcinoma Human liver mesenchymal stem/progenitor cells inhibit hepatic stellate cell activation: in vitro and in vivo evaluation.Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1α Truncated active human matrix metalloproteinase-8 delivered by a chimeric adenovirus-hepatitis B virus vector ameliorates rat liver cirrhosis.Gene expression profiling reveals underlying molecular mechanism of hepatoprotective effect of Phyllanthus niruri on thioacetamide-induced hepatotoxicity in Sprague Dawley rats Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.Serum osteopontin predicts degree of hepatic fibrosis and serves as a biomarker in patients with hepatitis C virus infection.Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.Adipose triglyceride lipase is involved in the mobilization of triglyceride and retinoid stores of hepatic stellate cells.Treatment with 4-methylpyrazole modulated stellate cells and natural killer cells and ameliorated liver fibrosis in mice.Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan.A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages.Inhibition of liver fibrosis using vitamin A-coupled liposomes to deliver matrix metalloproteinase-2 siRNA in vitro.Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells.Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA.Adipose tissue-liver axis in alcoholic liver disease.Zebrafish models of human liver development and disease 3D Spheroid Culture Enhances the Expression of Antifibrotic Factors in Human Adipose-Derived MSCs and Improves Their Therapeutic Effects on Hepatic Fibrosis.Hypoxia-inducible factor 1-regulated lysyl oxidase is involved in Staphylococcus aureus abscess formation Inhibition of SIRT2 suppresses hepatic fibrosis.Liver Injury and the Activation of the Hepatic Myofibroblasts.Microvascular targets for anti-fibrotic therapeutics

P2860

Q26745650-CA695A93-6F14-44CD-B9D7-C560818C3488 Q26750543-97363A1F-FB40-4C55-BC4B-529EE3A86D83 Q26752622-2ED9324C-C9B5-45E9-A316-27356BE912CB Q26753043-945627D2-D52C-42AD-B1B1-72ED6B6F23F6 Q26773384-31760CAF-6662-46BB-945C-98A397A414DA Q26850412-7E7D2FF1-CA4C-4FD3-8636-1B291080D91E Q27011111-6E488A56-0581-49C6-A565-53AC31509EA2 Q28071678-BFD348C4-25B2-4664-96D8-6876105A73F3 Q28085644-CB780480-F75D-48EB-9068-5F17FE71E260 Q28545190-75A2C991-9937-4C96-A7CB-A5E61BC6B8AD Q30369750-DB475B0F-3657-4265-A16E-A502DE227531 Q30374500-96FB747E-67BA-4DB1-ADBD-8F96390B2AB8 Q30375693-D61BB17C-4015-4E0E-ABF8-F0903ADBE151 Q30384757-38A46EB1-6AA4-4792-B807-4B47580E9561 Q30414378-31DFB0B9-2C9D-47B4-87AD-A491839517A6 Q33563882-8E0AC398-A388-4A39-9F28-165FE150F310 Q33638924-95E88694-C552-4B97-B16A-4BBB21C88DAD Q33661028-B7209FC2-E434-41BA-BE68-826032957D1D Q33768416-C7C113FC-5975-4A03-B003-CEB5D0200D56 Q33971462-C266A830-3FAD-40F4-B8CE-2FE0EE882D0F Q34542461-C199FA8A-016B-4973-A30B-50DB196FCC9A Q34800228-60DCAAA1-E667-4170-BA98-8D2D5B7A6602 Q34985947-11F30944-2CAE-4B43-B599-1978EC216694 Q35168268-7A52DF5F-96D6-4E66-B1A6-76644FE98EF1 Q35450695-035FB10C-CED5-4EAB-A4D2-A0494D9F936A Q35533232-FDF9889A-20AB-43E8-A526-A3F22A844C00 Q35646227-419323BD-187D-4B2C-99B3-BA5CA2542EEB Q35803687-BDCD1242-D0B7-4BA5-944A-D2044B713ED8 Q35819563-592EEE06-D28A-4D16-9E1C-1345F8CEF136 Q35898018-B2DD5092-04BB-4951-A1B6-D089C428A7BA Q35919793-B4AF9FEF-34E1-4E4E-80ED-D2AD74AD09A7 Q36175084-20D34168-9D83-43BF-82F2-70C7CED294AE Q36301298-0C887457-9889-4024-ACAA-9A592F327526 Q36578908-B294DA04-82B7-4A57-BA5D-7A9B410D0F01 Q36669372-C04FEA99-4240-4296-801B-F0AA0B0561F4 Q36679690-71558D04-F3A6-4465-9A2D-3950F9B357AA Q36970819-DBB20B22-C492-4D91-A791-192DB8F4D8A6 Q37071786-15C2DC1D-26FF-4078-9DD4-8A51661F2439 Q37109402-8DE985EB-7005-48C8-85A3-1A91BE648352 Q37358577-32A83DDD-2BF8-44AB-BCDE-A5F27C6AF69C

P2860

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

http://www.wikidata.org/entity/Q35209239

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@ast

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@en

type

label

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@ast

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@en

prefLabel

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@ast

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.

@en

P1433

Q35209239-D16E359B-9E71-466D-8029-D222B49DA533

P1476

Q35209239-261BC384-D852-4E15-941D-DCBDD4D850A0

P2093

Q35209239-39D2A32F-1FB4-418B-A3F2-2A50C81852D3

Q35209239-3DB23EBB-0F6D-4DA7-87A6-1AFB5C5F57B1

P2860

Q35209239-003869D0-C1FC-4801-90E6-93BE88047AD4

Q35209239-01278EB0-E697-48A6-8E22-73EA55DA837C

Q35209239-014DEF7E-C84A-4181-AEB9-2F5E305B83EE

Q35209239-0996B89C-388C-43C7-81BF-B8AC835BABE8

Q35209239-09A7E614-2057-4E12-892A-9AB2FB83DF86

Q35209239-0A0D349A-0CD3-496C-A165-ADD26DD2F277

Q35209239-0BE9EF48-82DC-4874-9BA0-45557B92A0BB

Q35209239-0E524EED-4203-4B18-BB37-A36240A677F2

Q35209239-0EA56954-538C-4A98-A5E5-385675930CDE

Q35209239-13F436F0-E7C4-46BB-B05E-AC0A417BC9CC

P304

Q35209239-39C2A10F-2FC2-485C-99F5-27EAF11DCD56

P31

Q35209239-42F6FA50-0B3A-4B73-B490-23206B5CCB0B

P356

Q35209239-9E0EEEA6-931D-40E1-AA31-A87945E48D67

P433

Q35209239-87D59149-D99D-4CD4-B000-49F6C1FCA1C7

P478

Q35209239-1078B5C8-464C-4638-ABC8-88C2CB2DEA11

P50

Q35209239-29CEE8A4-42C0-4A2E-BDB7-C240F3C54341

P577

Q35209239-1FFC76C7-CA46-4DFB-B5B4-0F00C34E7A2B

P5875

Q35209239-7E925284-B61D-4460-8ACE-43339D3773FF

P698

Q35209239-2D016D36-19B4-43E8-ABEF-B62C6A598D1C

P921

Q35209239-B1C1360A-2010-40DC-982F-1C774B86AAE7

P932

Q35209239-027346CE-916E-4138-B37B-35A2E4BF30C3

P356

J.CBI.2011.07.001

P1433

Chemico-biological Interactions

P1476

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches

@en

P2093

Elisabetta Mormone

http://www.w3.org/2001/XMLSchema#string

Natalia Nieto

http://www.w3.org/2001/XMLSchema#string

P2860

Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen

Inhibition of translational initiation by Let-7 MicroRNA in human cells

Global epidemiology of hepatitis B virus

Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells

MicroRNAs in the Hox network: an apparent link to posterior prevalence

Mechanisms of hepatic fibrogenesis

Cytokine regulation of hepatic stellate cells in liver fibrosis.

P304

225-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CBI.2011.07.001

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

193

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51534321

http://www.w3.org/2001/XMLSchema#string

P698

21803030

http://www.w3.org/2001/XMLSchema#string

P921

P932

3171510

http://www.w3.org/2001/XMLSchema#string